https://yestino.com/entities/gilead-01aa3fEvery event involving Gileadenhttps://yestino.com/events/fda-approves-daily-hiv-pill-from-gilead-designed-to-simplify-09f171https://yestino.com/events/fda-approves-daily-hiv-pill-from-gilead-designed-to-simplify-09f171Thu, 27 Aug 2026 21:49:18 GMTThe new pill is also aimed at people who are doing well on a single-tablet regimen, including Biktarvy, and want to switch to a new treatment. Sources: CNBC Business